These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36127076)

  • 21. COVID-19 infection risk assessment and management at the Tokyo 2020 Olympic and Paralympic Games: A scoping review.
    Murakami M; Fujii K; Naito W; Kamo M; Kitajima M; Yasutaka T; Imoto S
    J Infect Public Health; 2024 Apr; 17 Suppl 1():18-26. PubMed ID: 37032255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global warming and the Summer Olympic and Paralympic games: a perspective from the Tokyo 2020 Games.
    Yamasaki L; Nomura S
    Environ Health Prev Med; 2022; 27():7. PubMed ID: 35288491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases.
    Toumi A; Zhao H; Chhatwal J; Linas BP; Ayer T
    JAMA Netw Open; 2021 Aug; 4(8):e2119621. PubMed ID: 34402891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020.
    Yashio T; Murayama A; Kami M; Ozaki A; Tanimoto T; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 44():102205. PubMed ID: 34785374
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games.
    Urashima M; Takao H; Sakano T; Takeshita K; Yoshida M; Nakazawa Y; Kawai M; Murayama Y
    Intern Med; 2022 Dec; 61(24):3659-3666. PubMed ID: 36198605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games.
    Gallego V; Nishiura H; Sah R; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2020; 34():101604. PubMed ID: 32112859
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk Assessment of Dengue Autochthonous Infections in Tokyo during Summer, Especially in the Period of the 2020 Olympic Games.
    Ishikawa H; Shimogawara R
    Jpn J Infect Dis; 2019 Nov; 72(6):399-406. PubMed ID: 31366859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics and courses of COVID-19 in patients from the first through fifth waves of the disease: Focused on a single public health center in Tokyo, Japan].
    Hijikata N; Murakami K; Uehara S; Shibuya K; Fukuda Y
    Nihon Koshu Eisei Zasshi; 2024 Feb; 71(2):117-123. PubMed ID: 38008459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Existential threats to the Summer Olympic and Paralympic Games? a review of emerging environmental health risks.
    Annear M; Kidokoro T; Shimizu Y
    Rev Environ Health; 2021 Jun; 36(2):159-166. PubMed ID: 34981705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of COVID-19 cases during Tokyo's Olympic and Paralympic Games.
    Tokuda Y; Kuniya T
    J Gen Fam Med; 2021 Jul; 22(4):171-172. PubMed ID: 34221790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Tokyo 2020 Olympic and Paralympic pharmacy services during the COVID-19 pandemic.
    Kasashi K; Sato A; Stuart M; Hollywood Ú; Kawaguchi-Suzuki M; Yagishita K; Akama T
    J Am Pharm Assoc (2003); 2023; 63(4):1156-1161. PubMed ID: 36965764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contributions of the Tokyo 2020 Infectious Diseases Control Centre in curbing SARS-CoV-2 spread during the Olympic and Paralympic Games.
    Shimada S; Ikenoue C; Iwashita Y; Miyamoto T
    Br J Sports Med; 2023 Jan; 57(1):6-7. PubMed ID: 36113974
    [No Abstract]   [Full Text] [Related]  

  • 33. Doping control analyses during the Tokyo 2020 Olympic and Paralympic Games.
    Okano M; Ikekita A; Sato M; Inoue T; Kageyama S; Akiyama K; Aoi A; Miyamoto A; Momobayashi A; Ota M; Ishige M; Sakurai H; Shiomura S; Takemine M; Watanabe Y; Hikota T
    Drug Test Anal; 2022 Nov; 14(11-12):1836-1852. PubMed ID: 36208085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Team USA COVID-19 Prevalence at Tokyo 2020 Summer Olympic and Paralympic Games.
    Adams WM; Anderson T; Finnoff JT
    Curr Sports Med Rep; 2023 Feb; 22(2):49-51. PubMed ID: 36757122
    [No Abstract]   [Full Text] [Related]  

  • 35. Physical Activity Among Urban-Living Middle-Aged and Older Japanese During the Build-Up to the Tokyo Olympic and Paralympic Games: A Population Study.
    Annear M; Kidokoro T; Shimizu Y
    J Aging Phys Act; 2021 Apr; 29(2):308-318. PubMed ID: 33091871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games.
    Akashi H; Shimada S; Tamura T; Chinda E; Kokudo N
    JAMA; 2022 Mar; 327(10):978-980. PubMed ID: 35113161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necessity and challenges for the post-pandemic Hangzhou Asian Games: An interdisciplinary data science assessment.
    Guo J; Zhang X; Cui D
    Front Psychol; 2022; 13():1047990. PubMed ID: 36636667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health risks and precautions for visitors to the Tokyo 2020 Olympic and Paralympic Games.
    Nakamura S; Wada K; Yanagisawa N; Smith DR
    Travel Med Infect Dis; 2018; 22():3-7. PubMed ID: 29360525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Care Management Based on Disaster Medicine for the Triathlon Events at the XXXII Olympiad and Tokyo 2020 Paralympic Games.
    Yagi M; Kasanami R; Tarumi Y; Dohi K
    Int J Environ Res Public Health; 2023 Oct; 20(19):. PubMed ID: 37835161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status and future directions of comprehensive tobacco control policies for the 2020 Tokyo Olympic Games: A review.
    Li M; Tada A; Kiya M; Okamoto R
    Tob Induc Dis; 2019; 17():24. PubMed ID: 31582935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.